“Endovascular treatment of carotid artery stenosis: evidences from randomized controlled trials and actual indications” Monaldi Archives for Chest Disease, Cardiac Series - volume 76, 4 – 2011 Dec.
“Cardiac Side Effects of Chemotherapy: State of Art and Strategies for a Correct Management” Current Vascular Pharmacology, 2012 May.
“The role of atherectomy in the treatment of lower extremity peripheral artery disease” BMC Surgery, 2012 May.
“Abdominal Aortic Aneurysm in patients affected by intermittent claudication: prevalence and clinical predictors” BMC surgery, 2012 May.
“Endovascular Treatment of lower extremity arteries is associated with an improved outcome in diabetic patients affected by intermittent claudication” BMC surgery, 2012 May.
“Ankle/Brachial Index to everyone” BMC Surgery, 2012 Nov.
“Use of statins in lower extremity artery disease: a review” BMC surgery, 2012 Nov.
“Prothymosin alpha protects cardiomyocytes against ischemia-induced apoptosis via preservation of Akt activation” Apoptosis. 2013 Oct.
“Percutaneous Coronary Intervention in a Patient with Acute Thrombosis of Saphenous Vein Graft and Patent Native Coronary Artery: Which is the Vessel to Approach?” AIMS Medical Science. 2015 Sept.
“Determinants of myocardial mechanics in top-level endurance athletes: three-dimensional speckle tracking evaluation.” Eur Heart J Cardiovasc Imaging. 2016 Jun.
“Abluminal biodegradable polymer-based Biolimus A9-eluting stent for the treatment of infrapopliteal arteries in critical limb ischemia: Long-term follow-up.” Int J Cardiol. 2016 Jan.
“Diabetes does not impact the diagnostic performance of contrast-based fractional flow reserve: insights from the CONTRAST study” Cardiovascular Diabetology 2017 Jan.
“Translational Research: The Cornerstone for Medical Technology Advancement.” Toxicol Pathol. 2019 Apr.
“Current concepts regarding drug dosing for peripheral stents” J Cardiovasc Surg. 2019 May.
“Long-term performance and biocompatibility of a novel bioresorbable scaffold for peripheral arteries: A three-year pilot study in Yucatán miniswine” Catheterization Cardiovascular intervention. February 2020
“Impact of Coronary Atherosclerosis on Bioresorbable Vascular Scaffold Resorption and Vessel Wall Integration” JACC: Basic to translational science. June 2020.
“First in human evaluation of a novel Sirolimus-eluting ultra-high molecular weight bioresorbable scaffold: 9-, 24-and 36-months imaging and clinical results from the multi-center RENASCENT study” International Journal of Cardiology. August 2020.
“First-in-human evaluation of the novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold: 9- and 24-month imaging and clinical results of the RENASCENT II trial.” Eurointervention. March 2020.
“Complete revascularization in acute and chronic coronary Syndrome” Cardiology clinics. November 2020.
“Impact of chronic kidney disease on platlet aggregation in patients with acute coronary syndrome” Journal of Cardiovasc Medicine. September 2020.
“Downstream Paclitaxel Released Following Drug-Coated Balloon Inflation and Distal Limb Wound Healing in Swine” JACC: Basic to translational science. May 2021.
"RENASCENT III: First in Human Evaluation of the Novel Thin Strut MAGNITUDE Sirolimus-Eluting Ultra-High Molecular Weight MAGNITUDE Bioresorbable Scaffold: 9-months Imaging and 2-Year Clinical Results." Circulation Cardiovascular Intervention. May 2021.
“Partial closure with a self-made fenestrated device of secundum atrial septal defect with severe pulmonary artery hypertension in adults.” Journal Geriatric Cardiology. June 2021
“Three-years outcome of directional atherectomy and anti-restenotic therapy (DAART) for the 3 treatment of common femoral artery steno-occlusive lesions.” Catheterization cardiovascular intervention. March 2022